project id: TCGA-ACC; case submitter id: TCGA-OR-A5L5; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.72; rna integrity number: 8.6; age at index: 77; days to birth: -28270; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1933; age at diagnosis: 28270; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1317.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: Not Reported; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 828; initial weight: 70.0; sample id: 321a91ce-7cc6-49e0-9e50-130db43db7f5; sample submitter id: TCGA-OR-A5L5-01A; portion id: b528e616-3683-466d-8127-9d1d6ff9e5b0; portion submitter id: TCGA-OR-A5L5-01A-11; slide id: 9d4f9e53-929c-4e97-9ab6-aaae69af05bc; slide submitter id: TCGA-OR-A5L5-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0; section location: TOP;